Updated: Mar 30
When Corstrata founders and veteran healthcare executives Katherine Piette and Joseph Ebberwein sought to make an impact in the vast U.S. healthcare system, the $33B wound care market was their choice. Having worked for decades with thousands of patients, practitioners and administrators who struggled to heal complex wounds, they applied their professional experience and problem-solving skills to create Corstrata, an innovative, comprehensive, virtual wound care management company. Patient consultation using telemedicine technology is the foundation of the company’s services. Corstrata wound care nurses conduct video consultations with patients in their home, in a healthcare facility, or at their doctor’s office. With Corstrata’s mobile application, wound characteristics are analyzed, tracked, and documented. Appropriate wound care management strategies and dressing options are recommended, and patient follow up is scheduled on a routine and as-needed basis.
The growing number of wound patients in the U.S. is being driven by an aging population and ongoing increases in chronic diseases such as diabetes, heart disease, and renal failure. With over 6.5M wound patients today, by 2020, that number is estimated to grow to 8.7M. The current deficit in available Certified Wound Specialist nurses is severe. To adequately address current wound care needs in health care facilities and home health care today, 27,900 expert wound nurses are needed, but there are only 5,400 currently in practice. Corstrata addresses that major issue by making wound care nurses’ expertise available through remote consultations via its wound care management company, thus leveraging this scarce resource and extending expert consultation to patients in underserved locales such as rural areas.
Home health agencies, third party administrators of self-funded employer insurance programs (TPAs), clinically integrated networks of doctors and related practitioners (CINs), and direct care physicians (DCPs) can acquire a wide variety of Corstrata services such as its Comprehensive Wound Management Programs or complement their existing wound management resources with specific services such as program policy and procedure assessment, product formulary design, treatment guidelines assessment, wound documentation review, and practitioner education. Skilled nursing facilities and hospices also can benefit from Corstrata's wound care management company care services, as can veteran health care services.
Katherine Piette, Co-founder and CEO, remarked, “Documented Corstrata case studies have proven that our unique combination of experts and technologies enables providers and administrators to markedly improve healing rates, significantly reduce costs, and contribute to higher institutional quality scores.” Ms. Piette has held senior leadership positions in marketing, performance excellence, strategic positioning, and organizational redesign for wound care management of high risk, high cost populations.
Joseph Ebberwein, Co-founder and CFO, noted, “Corstrata decided to embrace the challenge of reducing patients’ pain, suffering and despair when wounds are not healing on a timely basis, and at the same time, to support improved efficacy for and cost of treatment by providers.” Mr. Ebberwein has served in senior leadership roles in operations, finance, and business strategy during his 30 year career in the home health and hospice industries. Corstrata has attracted a multidisciplinary leadership team and board of clinical advisors drawn from national leaders in the wound industry including Carolyn Cuttino, Jan Cuzzell, Susan Wickard, Myra Varnado, Dot Weir, Lee Ruotsi and Harriett Loehne.
Launched in 2015, Corstrata’s wound care management company's plans for the future are ambitious, with on-going expansion into new states, and formation of wound care hubs to serve clusters of home health agencies and other consortia-type healthcare providers and administrators. Capturing valuable information regarding the most effective treatments and wound management strategies will enable Corstrata to perform predictive analytics to predetermine which treatment protocols and practices are most effective for a variety of diagnoses. Through participation in industry conferences and research, Corstrata regularly invites customers, partners, and industry experts to contribute to its pioneering vision for “Expert Wound Care. Anywhere.”
Corstrata was founded in 2015 to deliver innovative wound care management services and address the shortage of expertise in this $33B U.S. market. Home health agencies, third party administrators of self-funded employer insurance programs (TPAs), clinically integrated networks of doctors and related practitioners (CINs), and direct care physicians (DCPs) can benefit from Corstrata’s unique combination of professional expertise, digital technologies and telemedicine to treat wound patients and support practitioners anywhere, any time. The company delivers a Comprehensive Wound Care Management Program, Wound Patient Consultations, and specific services such as program, policy and procedure assessment, formulary design, treatment guidelines assessment, wound documentation review, and practitioner education. Wound program development is available for Pressure Ulcer Prevention and Management, Diabetes Foot Ulcer Prevention and Management, Ostomy Care and Management, and Palliative Wound Management.